Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Cell Microenvironment" patented technology

Isolated organ preserving device and preserving method thereof

The invention relates to an isolated organ preserving device and a preserving method thereof, and belongs to the technical field of medical equipment. The isolated organ preserving device is structurally characterized in that continuous mechanical irrigation and membrane oxygenation are adopted, an isolated organ continuously obtains nutrients and the oxygen supply, a cell metabolite is removed in time, and a cell microenvironment is better maintained, so that the function normality is ensured. The isolated organ preserving device disclosed by the invention can be used for directly contacting the organ perfusate and the organ perfusion instrument by adopting a disposable consumable material sterilized through epoxyethane, thereby meeting the requirement for sterility of a system. Besides, the isolated organ preserving device disclosed by the invention can be used for judging the consumption of the nutrients contained in the organ perfusate and the gathering degree of metabolic wastes by monitoring the pH value of the organ perfusate in real time and can be used for abandoning the organ perfusate after a certain standard is achieved and replacing the fresh organ perfusate, thereby further ensuring the possibility of long-time preservation; the isolated organ preserving device can be used for evaluating the damage condition of the isolated organ by monitoring the front and back perfusion pressure of the isolated organ in real time and converting the perfusion resistance by combining a flow number.
Owner:江苏赛谷细胞工程研究院有限公司

Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention

ActiveUS20050107294A1Prevents amputationAssisting in limb preservationOrganic active ingredientsPowder deliveryAngiologyDiabetic foot
The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and/or microvasculature, patients with inadequate lymphatic and/or venous return and ulcers or other lesions which are difficult to cicatrise and/or heal.
Owner:CENT DE ING GENETICA & BIOTECNOLOGIA

Rhodamine fluorescent molecular probe using quinoline derivative as identification group and synthesis method thereof

The invention provides a rhodamine fluorescent molecular probe using a quinoline derivative as an identification group and a synthesis method thereof, and relates to a rhodamine fluorescent molecular probe and a synthesis method thereof, solving the problem that the existing rhodamine fluorescent probe molecules based on the quinoline derivative identification group are few. A structural formula of a fluorescent molecular probe is as shown in specifications. A preparation method comprises the following steps: 1, preparing reaction liquid; and 2, adjusting the pH value of the reaction liquid, carrying out spin-drying and performing silica gel column chromatographic separation to obtain the rhodamine fluorescent molecular probe using the quinoline derivative as the identification group. A structural formula of another fluorescent molecular probe is as shown in specifications. A preparation method comprises the following steps: 1, preparing an intermediate rhodamine B hydrazide; and 2, dissolving the intermediate rhodamine B hydrazide and a quinoline-2-aldehyde derivative into absolute ethanol, refluxing under the protection of nitrogen, carrying out spin-drying and performing silica gel column chromatographic separation to obtain the rhodamine fluorescent molecular probe using the quinoline derivative as the identification group. The rhodamine fluorescent molecular probe disclosed by the invention is applied to the field of fluorescent imaging detection of metal ions in biological tissues and cell microenvironments.
Owner:QIQIHAR UNIVERSITY

Environment-sensitive tumor-targeting polymer micelle and preparation method thereof

The invention belongs to the technical field of biology, relates to environment-sensitive tumor-targeting polymer micelle and a preparation method thereof, and especially relates to a cell microenvironment-sensitive oxidized ascorbic acid-modified tumor-targeting polymer micelle administration system and a preparation method thereof. An administration system realizes delivery in tumor by a glucose transporter mechanism, the polymer micelle of which the inner core has a disulfide bond crosslinked barrier is designed by use of the GSH characteristics of high density in the cell microenvironment, drug release characteristics trigged by the cell microenvironment are obtained, and the environment-sensitive tumor-targeting polymer micelle has a high transport capability, a fast transport rate and difficult saturation. Compared with polypeptide protein molecules, the environment-sensitive tumor-targeting polymer micelle has the characteristics of simple synthesis preparation, high stability and no immunogenicity. Through synergism of targeting and structure stabilization, drug delivery to a target position and a target cell is realized so that drug delivery efficiency is greatly improved and thus the environment-sensitive tumor-targeting polymer micelle has a good clinical application prospect.
Owner:FUDAN UNIV

Preparation method of cell nutrient solution for promoting hair regeneration

The invention provides a preparation method of a cell nutrient solution for promoting hair regeneration. The preparation method mainly comprises three steps: 1) primary isolation of ADSCs (adipose-derived stem cells); 2) enlarged cultivation of the ADSCs; and 3) induced culture of the ADSCs. The cell nutrient solution prepared by the invention can solve the problem of alopecia from the point of cell regeneration; the ADSCs-conditioned medium (the nutrient solution), in a periodic hair follicle reconstruction process, can activate a stem cell microenvironment of hair follicle and can regulate and control the normal growth of the hair follicle; by conducting low-dose UVB radiation, ADSCs survival, migration and paracrine capacities can be significantly improved, and an angiogenesis capacity and a hair regeneration capacity can be also obviously improved; by cultivating the ADSCs with a fibroblast-conditioned medium, cell survival and metabolism processes in a body environment can be simulated, and the secretion of more cell factors, which are conducive to cell microenvironment regulation and control, from cells can be promoted; and meanwhile, the cell nutrient solution prepared by the method is convenient in cell preparation, broad in source and convenient for clinical popularization, and cells can be derived from fat wastes obtained from clinical liposuction and skin grafts removed in other surgical operations.
Owner:陕西佰瑞衡健康科技有限公司

Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF)

InactiveUS7465704B2Prevents amputationAssisting in limb preservationOrganic active ingredientsPowder deliveryAngiologySurgical department
The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and / or microvasculature, patients with inadequate lymphatic and / or venous return and ulcers or other lesions which are difficult to cicatrise and / or heal.
Owner:CENT DE ING GENETICA & BIOTECNOLOGIA

Method for reducing plant cell browning risk through absorption of quinone substances with silica gel

The present invention discloses a method for reducing plant cell browning risk through absorption of quinone substances with silica gel. The method comprises: preparing a silica gel absorption material having a specific shape, and sterilizing so as to be spare; during a cell culture process, completely contacting the silica gel absorption material and a plant cell culture, wherein the color of the silica gel absorption material is changed into red-brown after absorbing quinone substances; and taking out the silica gel absorption material after the absorption achieves a saturation state or the culture is completed. According to the present invention, the silica gel is selected as the absorption agent for the cell browning related quinone substances so as to avoid absorption on cell nutrients in the culture medium, reduce the content of the quinone substances in the cell microenvironment, avoid plant (Taxus chinensis) cell browning death, and easily increase stability and cell activity of plant (Taxus chinensis) cell culture; and browning generally causes the decreased cell metabolism level, such that the secondary metabolite having drug activity in the cells can be increased by using silica gel absorption to avoid browning, wherein the yield of the anticancer drug paclitaxel in the Taxus chinensis cells can be increased.
Owner:SHANGHAI JIAO TONG UNIV

Active oxygen content automatic detection system suitable for cell microenvironment

The invention relates to a biochemical detection instrument. The invention aims to provide a rapid, accurate and automatic detection system for realizing the trace volume of a large number of ROS content samples aiming at cell, tissue and organ microenvironments such as pleural fluid, peritoneal fluid, cerebrospinal fluid, amniotic fluid, follicular fluid, cell culture fluid and the like. The technical scheme is as follows: the active oxygen content automatic detection system suitable for a cell microenvironment is characterized in that the automatic detection system comprises a sample transmission reaction system, a detection system, a washing system communicated with the sample transmission reaction system through a water pipe pipeline and a purging system communicated with the sample transmission reaction system through an air pipe pipeline, wherein the sample transmission reaction system and the detection system are sequentially communicated through a light shielding pipeline; thesample transmission reaction system comprises a sample injector and a DCFH supply bin which are connected in parallel and then communicated with a reaction bin through a light shielding pipeline; andsample injection valves are respectively arranged between the sample injector and the reaction bin and between the DCFH supply bin and the reaction bin.
Owner:ZHEJIANG UNIV

Application of dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer

The invention discloses a dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer and a preparation method thereof, which relates to a dual-fluorophore ratio fluorescence molecular probe and a preparation method thereof. The dual-fluorophore ratio fluorescence molecular probe and the preparation method thereof disclosed by the invention are designed for solving the technical problems that due to energy loss caused by energy transfer between double fluorophores when the existing dual-fluorophore ratio fluorescence molecular probes are excited, the probes are poor in fluorescence, and not high in metal ion selectivity and sensitivity. The structure formula of the dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer is shown in the specification. The preparation method of the dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer comprises the steps of 1, preparing an intermediate; and 2, preparing the dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer. The dual-fluorophore ratio fluorescence molecular probe disclosed by the invention can be applied to the fluorescence imaging detection of metal ions in biological tissue and cell microenvironments.
Owner:QIQIHAR UNIVERSITY

Ac-SDKP-LDH nanocrystallization preparation as well as preparation method and application thereof

The invention discloses an Ac-SDKP-LDH nanocrystallization preparation as well as a preparation method and application thereof. The Ac-SDKP-LDH nanocrystallization preparation comprises LDH and Ac-SDKP inserted between LDH layers and is prepared through the following steps that the LDH and the Ac-SDKP are fully mixed and react at the temperature of 2-8 DEG C for 8-24 h, the Ac-SDKP is inserted between the LDH layers through ion exchange, and the Ac-SDKP-LDH nanocrystallization preparation is obtained. The Ac-SDKP-LDH nanocrystallization preparation disclosed by the invention can be used for preparing anti-silicofibrosis medicines. The method for preparing the Ac-SDKP-LDH nanocrystallization preparation is simple and easy to operate, and according to the prepared Ac-SDKP-LDH nanocrystallization preparation, under the action of a cell microenvironment, a cationic laminate of LDH dissolves in inorganic metal ions, so that the Ac-SDKP is released, the effect of protecting the Ac-SDKP is achieved, the anti-EMT effect can be sufficiently exerted, and the Ac-SDKP-LDH nanocrystallization preparation is used for preventing and treating silicosis fibrosis and has the medicine controlled release characteristics of long lasting time, high biological safety and pH sensitivity. In addition, the LDH has a certain anti-fibrosis effect, and the anti-fibrosis effect of the LDH is enhanced by compounding the LDH and the Ac-SDKP.
Owner:复旦大学附属中山医院青浦分院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products